S2P Pep-LNP
Cat. No.: TDLD-0126-LD134
S2P Pep-LNP
S2P Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered for targeted drug delivery. The S2P peptide enables specific binding, enhancing therapeutic efficacy, while its design supports stability and reduced immunogenicity. Applications include targeted delivery research in nanomedicine. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | S2P Peptide |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
T7 Pep-LNP (TDLD-0825-LD74)
PCM Pep-LNP (TDLD-0825-LD93)
RVG29 Pep-LNP (TDLD-0825-LD72)
iNGR Pep-LNP (TDLD-0126-LD107)
PF6 Pep-LNP (TDLD-0126-LD127)
CD147 CAR mRNA-LNP (TDLD-0825-LD54)
RGES Pep-LNP (TDLD-0126-LD132)
CSTSMLKAC Pep-LNP (TDLD-0126-LD79)
Online Inquiry
